Retatrutide, from Soma Corp., is gaining increasing attention as a innovative method for weight control . This innovative drug integrates the mechanism of a GLP-1 receptor activator and a GIP receptor stimulant, intended to effectively promote weight loss but also improve related metabolic factors. Initial patient studies have indicated impressive